Novel paclitaxel formulation encouraging for treating advanced lung cancer
Tuesday, June 15, 2010 - 14:20
in Health & Medicine
Researchers report the results of a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer.